Early Diagnosis and Results of Enzyme Replacement Therapy in the Patient with Mucopolysaccharidosis Type VI: Clinical Case

Background. Mucopolysaccharidosis type VI (MPS VI, Maroteaux–Lamy syndrome) is rare autosomal-recessive multisystem disease, one of the group of lysosomal storage diseases. The MPS VI pathogenesis is determined by arylsulfatase B enzyme deficiency caused by mutations in the ARSB gene. There are only...

Full description

Bibliographic Details

Published in:	Вопросы современной педиатрии
Main Authors:	Dmitry V. Ivanov, Anna I. Ostrun, Vladimir M. Kenis, Tatiana V. Markova, Ekaterina Yu. Zakharova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2021-12-01
Subjects:	mucopolysaccharidosis type vi maroteaux–lamy syndrome early diagnosis enzyme replacement therapy galsulfase clinical case
Online Access:	https://vsp.spr-journal.ru/jour/article/view/2776